News about Global Pharma

Vapotherm to Unveil Access365 Home Ventilation Solution at MEDTRADE

Vapotherm, Inc. announced the debut of its Access365™ Home Ventilation Solution at the upcoming MEDTRADE conference.

Global Pharma | 15/03/2024 | By Manvi |  284

Cardinal Health Announces Approved Science-Based Climate Targets; Expands Focus Across Supply Chain

Cardinal Health announced that the company has received approval by the Science Based Targets initiative (SBTi) for its near-term science-based greenhouse gas (GHG) emissions reduction targets.

Global Pharma | 15/03/2024 | By Manvi |  580

FDA Approves Rezdiffra (resmetirom) for Treatment of NASH with Liver Scarring

NASH, a consequence of nonalcoholic fatty liver disease, can lead to liver inflammation and scarring over time, resulting in liver dysfunction.

Global Pharma | 15/03/2024 | By Abha |  1926

CPHI Japan 2024 to See More Than 20 percent Year-on-Year Rise

The event is widely seen as a barometer of overall health in the country’s pharma industry and in light of significant R&D growth, Tides will collaborate with CPHI Japan to introduce a free conference.

Global Pharma | 14/03/2024 | By Manvi |  944

Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca

AstraZeneca to acquire Amolyt Pharma at a purchase price of USD 800 million upfront and a potential milestone payment of USD 250 million. Alexion, AstraZeneca Rare Disease is looking forward to welcoming talent from Amolyt Pharma.

Global Pharma | 14/03/2024 | By Manvi |  506

Poseida Therapeutics Receives FDA Orphan Drug Designation for P-BCMA-ALLO1 in Multiple Myeloma Treatment

P-BCMA-ALLO1 is a BCMA-targeted allogeneic, T stem cell memory (TSCM)-rich chimeric antigen receptor (CAR)-T therapy candidate, currently being investigated in collaboration with Roche for the treatment of relapsed/refractory multiple myeloma (RRMM).

Global Pharma | 14/03/2024 | By Abha |  606

IATA and Pharma.Aero Collaborate to Enhance Pharmaceutical Handling Excellence

The collaborative effort involved meticulous examination of the CEIV Pharma program, engaging certified entities, pharmaceutical manufacturers, and professionals within the air logistics sector.

Global Pharma | 14/03/2024 | By Abha |  690

Silicon Valley Innovations Appoints Thomas M. Krummel to its Board of Directors

Krummel recently received the 2023 Jacobson Innovation Award from the American College of Surgeons, the highest honor nationwide in Surgery, for his pioneering 'life-saving advances in newborn life support' and a 40 year career as an innovator in Surgery.

Global Pharma | 13/03/2024 | By Manvi |  490

Novartis Acquires IFM Due to Develop First-In-Class STING Antagonist Program Targeting Innate Immune System

The acquisition provides Novartis with full rights to IFM Due's portfolio of STING antagonists, which have the potential to treat an array of serious inflammation-driven diseases characterized by excessive interferon and other pro-inflammatory cytokine signaling.

Global Pharma | 13/03/2024 | By Manvi |  438

Casio Introduces DZ-C100 COLPOCAMERA and CST-100M Camera Stand to US, Australia and New Zealand

Alongside the devices, the image management software D'z IMAGE Viewer C is also available in these regions, marking a significant expansion of Casio's medical device offerings.

Global Pharma | 13/03/2024 | By Abha |  525